It is believed that HDAC inhibitors (HDACIs), as unique and generally effective neuroprotective agents, have the potential to radically improve the often bleak prognosis for brain trauma patients, thereby marking the first stride in tackling the silent epidemic of brain injury [14]. Here, HDAC9 is linked to brain injury.